DAFNA Capital Management LLC
Position in IPSC — Century Therapeutics, Inc.
CIK 1389933
LOS ANGELES, CA
Position in IPSC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,881,122
+$379,485 QoQ
Shares Held
2,400,458
-1.4% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#20
of 98 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. IPSC ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in IPSC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,881,122 | 2,400,458 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,501,637 | 2,434,353 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,779,618 | 2,793,586 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $848,707 | 1,704,232 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $952,665 | 1,704,232 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $811,214 | 1,704,232 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,721,274 | 1,704,232 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,914,236 | 1,704,232 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,345,791 | 1,704,232 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,464,961 | 1,307,407 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,340,591 | 1,307,407 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,614,814 | 1,307,407 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,131,406 | 1,307,407 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,536,702 | 1,307,407 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,438,632 | 475,367 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,701,379 | 475,367 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,993,082 | 475,367 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,234,270 | 256,892 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,588,141 | 100,135 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,012,800 | 80,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,347,200 | 80,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||